Value of Gym-based Exercise Training for Young Adults Receiving Antipsychotic Medication: The Vega Trial (Vega)

May 19, 2026 updated by: Bolette Rafn, Rigshospitalet, Denmark

Value of Gym-based Exercise Training for Young Adults Receiving Antipsychotic Medication: A Pragmatic, Single-blinded, Multicenter Randomized Controlled Trial

This is a multicentre, pragmatic, randomised controlled trial to estimate the effect of a 4-month gym-based exercise training program on 1) patient-rated personal recovery (primary outcome), 2) Health-related quality of life, behavioral and functional symptoms, and cardiometabolic risk factors (secondary outcomes) in young adults with psychotic disorders.

Four-hundred antipsychotic-treated young adults (between the age of 18 and 35), who are capable to undertake an exercise program (potentially with a friend or family member where possible) will be recruited from outpatient treatment units and mental health services. Participants will be randomised to treatment as usual or exercise at a 2:1 ratio in favor of exercise. Outcomes will be measured at baseline and at 4, 6 and 12 months after randomisation, by researchers masked to participant allocation.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Background:

Antipsychotic medications are associated with development of metabolic side-effects. Patients with schizophrenia have a four-fold higher prevalence of metabolic syndrome, and a two-to-three-fold higher risk of cardiovascular diseases compared to the general population. These factors may contribute to the premature mortality of 15-20 years observed in people with schizophrenia. The increased morbidity and mortality in people with mental illness can be explained by several risk factors, including physical inactivity.

Evidence suggests that exercise can have beneficial effects on multiple cardiometabolic outcomes, and improve clinical symptoms, quality of life, global functioning, and reduce negative and depressive symptoms in people with schizophrenia. In general, greater effects are seen for higher doses of aerobic exercise and motivational theory-based interventions supervised by exercise professionals. However, because of strict inclusion criteria, the external validity of existing studies is limited, and effectiveness studies are urgently needed

Objectives:

The primary objective is to determine the effectiveness of participation in a four-month supervised, gym-based exercise program among people treated with antipsychotic medication compared to usual care on patient-rated recovery (primary outcome).

Secondary objectives are to examine if the gym-based exercise program compared to usual care improves the following:

  1. Mental health
  2. Health-related quality of life
  3. Behavioral and functional symptoms
  4. Metabolic health

As tertiary objectives, we will investigate if:

  1. Prolongation of subsidized gym membership in addition to motivational text messages (extended support) will be superior to subsidized gym membership alone (minimal support), and to treatment as usual in relation to post-intervention adoption of physical activity.
  2. The exercise program impacts the quality of life and physical and mental health of the participants' primary relative.
  3. Participation in the gym-based program is associated with a reduction in the participants' use of mental health care services.
  4. The exercise program is cost-effective.

Design:

This is a multi-center, pragmatic, randomized (1:2) superiority trial to compare a 4-month, supervised, gym-based exercise training program to usual care. The pragmatic nature of the trial entails that it is designed to evaluate the effectiveness of interventions in real-life routine practice conditions.

In order to explore different ways to support sustainment (i.e., post-intervention adherence/adoption of physical activity), and to guide strategies to facilitate adherence, we will do "a study within a trial" (SWAT). Hence participants randomized to the intervention at baseline, will be randomized (allocation ratio 1:1) after four months to minimal vs. extended support with regards to sustainment of physical activity.

Study Type

Interventional

Enrollment (Actual)

226

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aalborg, Denmark, 9220
        • Aalborg University Hospital
      • Aarhus, Denmark, 8200
        • Aarhus University Hospital
      • Copenhagen, Denmark, 2100
        • Mental Health Centre Copenhagen
      • Glostrup Municipality, Denmark, 2600
        • Mental Health Centre Glostrup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • diagnosed with a psychotic disorder (F20-F29 Schizophrenia, schizotypal and delusional disorders) or an affective disorder (F30-F39 Mood [affective] disorders)
  • able to read and speak Danish or English

Exclusion Criteria:

  • advised from participating in exercise training by their treating doctor

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Vega Exercise Community
Participants will be offered one hour of tailored supervised, gym-based exercise training three times per week for a period of four months. In addition, participants are offered free-of-charge membership to the gym for six months and are invited to take part in training classes and use fitness equipment provided by the gym to regular members. The supervised program is tailored to meet the needs and requirements of this particular group of young adults and will include three weekly sessions of moderate-to-high intensity and mobility exercises.
The exercise sessions start with warm-up exercises, followed by 10-20 minutes resistance training (Part A), 10-20 minutes High Intensity Functional Training (HIFT) (Part B) and cool down. Instructors are allowed to make local adjustments as the delivery of the intervention is considered pragmatic. The participants can either perform the exercise together as one group, in pairs or one-by-one depending on individual needs and requests.
No Intervention: Usual care
Participants will receive treatment as usual and be informed of the official physical activity guidelines as part of the information on group allocation. Moreover, they will be advised to continue their daily living, as they normally would do, not guiding them to other interventions neither preventing them to do so. In addition, participants in the usual care group will be given a subsidized membership including access to the exercise classes for four months after the 12 months follow up.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Personal recovery
Time Frame: Baseline to four months
15-item Questionnaire about the Process of Recovery
Baseline to four months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Personal recovery
Time Frame: Baseline to six months and 12 months
15-item Questionnaire about the Process of Recovery
Baseline to six months and 12 months
Mental health
Time Frame: Baseline to four months
Mental Component Summary from the Short-Form 12 (SF-12) Health survey
Baseline to four months
Health-related quality of life
Time Frame: Baseline to four, six and 12 months
Short-Form 12 (SF-12) Health survey
Baseline to four, six and 12 months
Affective symptoms
Time Frame: Baseline to four, six and 12 months
Patient-Reported Outcomes Measurement Information System (PROMIS) Emotional distress
Baseline to four, six and 12 months
Physical Activity
Time Frame: Baseline to four, six and 12 months
International Physical Activity Questionnaire short form (IPAQ-SF)
Baseline to four, six and 12 months
Internalized Stigma
Time Frame: Baseline to four, six and 12 months
Internalized Stigma of Mental Illness Inventory (ISMI-9) short form
Baseline to four, six and 12 months
Use of substance (alcohol, cannabis, drugs)
Time Frame: Baseline to four, six and 12 months
Measured by self-developed items with responses for each substance: "never used", "use less than once a month", "regular use", "harmful use"
Baseline to four, six and 12 months
Sleep
Time Frame: Baseline to four, six and 12 months
Brief Pittsburgh Sleep Quality Index (B-PSQI)
Baseline to four, six and 12 months
Positive and negative symptoms
Time Frame: Baseline to four, six and 12 months
Colorado Symptom Index (MCSI)
Baseline to four, six and 12 months
Loneliness
Time Frame: Baseline to four, six and 12 months
Measured by a single item on a Likert scale of 4 levels: "During the past 12 months, have you felt lonely?"
Baseline to four, six and 12 months
Abdominal circumference
Time Frame: Baseline to four, six and 12 months
Measured with tape measure
Baseline to four, six and 12 months
Body weight
Time Frame: Baseline to four, six and 12 months
Measured on a scale
Baseline to four, six and 12 months
Skeletal muscle mass
Time Frame: Baseline to four, six and 12 months
Measured by bioimpedance
Baseline to four, six and 12 months
Total body fat
Time Frame: Baseline to four, six and 12 months
Measured by bioimpedance
Baseline to four, six and 12 months
Cardiorespiratory fitness
Time Frame: Baseline to four, six and 12 months
measured with the modified Ekblom-Bak submaximal cycle ergometer test
Baseline to four, six and 12 months
Blood pressure
Time Frame: Baseline to four, six and 12 months
measured by a digital blood pressure monitor
Baseline to four, six and 12 months
Resting heart rate
Time Frame: Baseline to four, six and 12 months
measured by a heart rate monitor
Baseline to four, six and 12 months
High density lipoproteins (HDL)
Time Frame: Baseline to four, six and 12 months
Taken from routine blood tests (mmol/l)
Baseline to four, six and 12 months
Low density lipoproteins (LDL)
Time Frame: Baseline to four, six and 12 months
Taken from routine blood tests (mmol/l)
Baseline to four, six and 12 months
Triglycerides
Time Frame: Baseline to four, six and 12 months
Taken from routine blood tests (mmol/l)
Baseline to four, six and 12 months
Glycosylated haemoglobin (HbA1c)
Time Frame: Baseline to four, six and 12 months
Taken from routine blood tests (mmol/l)
Baseline to four, six and 12 months
C-reactive protein (CRP)
Time Frame: Baseline to four, six and 12 months
Taken from routine blood tests (mg/L)
Baseline to four, six and 12 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Use of the subsidized membership
Time Frame: four to six months
To explore if prolongation of subsidized gym membership in addition to motivational text messages (extended support) is superior to subsidized gym membership alone (minimal support), and to treatment as usual in relation to post-intervention adoption of physical activity measured by use of the subsidized membership (intervention group only)
four to six months
Extended vs. minimal support for physical activity
Time Frame: four to six months
To explore if prolongation of subsidized gym membership in addition to motivational text messages (extended support) is superior to subsidized gym membership alone (minimal support), and to treatment as usual in relation to post-intervention adoption of physical activity measured by the IPAQ-SF (both groups).
four to six months
Quality of life of primary relatives to participants
Time Frame: Baseline to four, six and 12 months
To explore the impact of the Vega Exercise Community on the quality of life measured by SF-12 of the participants' primary relative
Baseline to four, six and 12 months
Sleep of primary relatives to participants
Time Frame: Baseline to four, six and 12 months
To explore the impact of the Vega Exercise Community on sleep (measured by B-PSQI) of the participants' primary relative
Baseline to four, six and 12 months
Mental health of primary relatives to participants
Time Frame: Baseline to four, six and 12 months
To explore the impact of the Vega Exercise Community on mental health (measured by PROMIS Emotional Distress-Depression - Short Form 4a) of the participants' primary relative
Baseline to four, six and 12 months
Physical activity of primary relatives to participants
Time Frame: Baseline to four, six and 12 months
To explore the impact of the Vega Exercise Community on physical activity (measured by IPAQ-SF) of the participants' primary relative
Baseline to four, six and 12 months
Utilization of mental health care services
Time Frame: 24 months and 60 months
To explore differences between groups of participants' long-term use of mental health care services, specifically number of inpatient and outpatient mental health contacts, including mental health emergency departments obtained from medical records
24 months and 60 months
Cost of the Vega Exercise Community
Time Frame: Baseline to four, six and 12 months
To explore the intervention cost i.e., education of instructors and delivery of exercise classes
Baseline to four, six and 12 months
Cost-effectiveness of the Vega Exercise Community
Time Frame: Baseline to four, six and 12 months
To explore the cost-effectiveness by comparing the cost and health-related quality of life, which will be measured by the EuroQol-5 Domain (EQ-5D)
Baseline to four, six and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 25, 2022

Primary Completion (Actual)

January 4, 2026

Study Completion (Actual)

January 4, 2026

Study Registration Dates

First Submitted

June 29, 2022

First Submitted That Met QC Criteria

July 15, 2022

First Posted (Actual)

July 18, 2022

Study Record Updates

Last Update Posted (Actual)

May 20, 2026

Last Update Submitted That Met QC Criteria

May 19, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • Vega Trial

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psychosis

Clinical Trials on Supervised exercise

Subscribe